baber/WOPTO huggingface dataset:
Patent NO-852872-L (NO)
Inventor: BOMMER JERRY C
IPC: A61K38/00
Filed: 1985-07-18
Abstract: This invention relates to a fluorescent mono, di- or polyamide of an aminodicarboxylic acid and a tetrapyrrole containing at least three carboxy groups of the structure:wherein Z is the amino acid residue and X is the tetrapyrrole residue and «n» an integer from 1 to 4 inclusive. Disclosed is also a process for the preparation of the new tetrapyrrole compounds. The new compounds are active and can be used in the preparation of pharmaceutical compositions for the treatment of tumors and cancerous tissues in the human or animal body.
Patent NO-863572-L (NO)
Inventor: FABRE FREDERIC
IPC: C01F17/206
Filed: 1986-09-08
Abstract: Rare-earth ores are treated with a concentrated aqueous solution of alkali metal hydroxide to recover the rare earths in the form of their hydroxides; the process is characterised in that the ore treatment is performed with stirring at a temperature of 100 to 220 DEG C at constant pressure and with a quantity of alkali metal hydroxide such that the sodium hydroxide/ore weight ratio is lower than 1 and higher than or equal to 0.5, or that the potassium hydroxide/ore ratio is lower than 1.4 and higher than or equal to 0.7
Patent NO-885360-L (NO)
Inventor: FLIER JEFFREY S
IPC: G01N33/68
Filed: 1988-12-01
Abstract: Method to distinguish between individuals who have normal metabolisms and gain weight due to overeating from those individuals who have a propensity to gain weight due to a genetic abnormality by detecting the level of the protein adipsin in the blood or the level of adipsin DNA in leukocytes. Method for treating genetic weight gain abnormality by administering therapeutic amounts of adipsin.
Patent NO-885738-L (NO)
Inventor: EIBL JOHANN
IPC: C07K16/00
Filed: 1988-12-23
Abstract: Proteins produced in cells collect together to form particulate aggregates. The invention relates to the reversible conversion of said aggregated proteins into morphological forms I, II and III which differ from one another, depending on the presence or absence of a non-denaturing detergent. The invention also relates to a process for the isolation and purification of said aggregated forms of proteins produced in cells.
Patent NO-893101-L (NO)
Inventor: COATES IAN HAROLD
IPC: A61P25/18
Filed: 1989-08-01
Abstract: The invention relates to tricyclic lactams of the general formula (I)   <CHEM>  wherein Im represents an imidazolyl group of the formula: <CHEM> and R<1> represents a hydrogen atom or a group selected from C1-6alkyl, C3-6alkenyl, C3-10alkynyl, C3-7cycloalkyl, C3-7cycloalkylC1-4alkyl-, phenyl, phenylC1-3alkyl-, -CO2R<5>, -COR<5>, -CONR<5>R<6> or -SO2R<5> (wherein R<5> and R<6>, which may be the same or different, each represents a hydrogen atom, a C1-6alkyl or C3-7cycloalkyl group, or a phenyl or phenylC1-4alkyl- group, in which the phenyl group is optionally substituted by one or more C1-4alkyl, C1-4alkoxy or hydroxy groups or halogen atoms, with the proviso that R<5> does not represent a hydrogen atom when R<1> represents a group -CO2R<5> or -SO2R<5>); one of the groups represented by R<2>, R<3> and R<4> is a hydrogen atom or a C1-6alkyl, C3-7cycloalkyl, C3-6alkenyl, phenyl or phenylC1-3alkyl- group, and each of the other two groups, which may be the same or different, represents a hydrogen atom or a C1-6alkyl group;  Y represents the group CH=CH or (CH2)n, wherein n represents 2 or 3; Q represents a halogen atom, or a group selected from hydroxy, C1-4alkoxy, phenylC1-3alkoxy-, C1-6alkyl, cyano, phenyl which may be unsubstituted or substituted by one or more C1-4alkyl, C1-4alkoxy or hydroxy groups or halogen atoms, -NR<7>R<8>, -CONR<7>R<8> or -(CH2)pCONR<7>R<8> (wherein R<7> and R<8>, which may be the same of different, each represents a hydrogen atom or a C1-4alkyl or C3-4alkenyl group, or together with the nitrogen atom to which they are attached form a saturated 5 to 7 membered ring; and p represents 1,2 or 3), -(CH2)qNR<9>R<1><0> (wherein R<9> represents a hydrogen atom or a C1-4alkyl group, and R<1><0> represents a group -COR<1><1> or -SO2R<1><1> wherein R<1><1> represents a C1-4alkyl group; and q represents 0, 1, 2 or 3), or -(CH2)2CO2R<1><1>(R<1><1> being as defined previously);  Q min  represents a hydrogen or a fluorine atom;  and physiologically acceptable salts and solvates thereof. The compounds are potent and selective antagonists of the effect of 5-HT at 5-HT3 receptors and are useful, for example, in the treatment of psychotic disorders, anxiety, and nausea and vomiting.
Patent NO-911705-L (NO)
Inventor: BASIN GERARD
IPC: E01C7/26
Filed: 1991-04-30
Abstract: Bituminous mix filled with a mineral wool and process for its preparation. 
<??>The mineral wool is characterised by its micron size; it is treated with a finish based on fatty acid amine oxide. 
<??>The process provides for the preparation of nodules from the mineral wool mat. 
<??>Application to terracings and road dressings and in particular with draining mixes. 
<IMAGE>
Patent NO-920817-L (NO)
Title: Innretning for fylling og lukning av pakninger for vaesker
Inventor: REIL WILHELM
IPC: B65B7/16
Filed: 1992-03-02
Abstract: Det er beskrevet en maskin for fylling og lukning av pakninger for væsker, hvor det i pakningenes topp- flate, som kan forbindes med en helle- anordning, er anordnet en åpning. Inn- retningen oppviser en første mate- transportør (3) med en ståflate for åpne, tomme pakninger (8), en transpor- tør (12) for intermitterende bevegelse av pakningene (8) fra en grunnstilling (I) til enkelte mellomstillinger (II-X, XI) og en endestilling (IX), og en fyllestasjon, en lukkestasjon, og en bortføringstransportør (25). For forbedring av maskinens ytelse er det sørget for at det i bevegelsesbanen bak matetransportøren (3) er anordnet en £;¿ tverrskyvetransportør, og det mellom matetransportøren (3) og bortførings- transportøren (25) er anordnet tverr- transportører og medbringeranordninger for intermitterende bevegelse av tran- sportkasser (14), og videre en mellom- transportør (12), og at fylle- og lukke- stasjonene er anordnet i området for tverrtransportørene på et nivå over transportkassene (14).
Patent NO-922786-L (NO)
Inventor: JUOLA VELI
IPC: H04B7/26
Filed: 1992-07-14
Abstract: A radio transceiver system is provided with transceivers for transmitting an outbound signal at least at one transmitting frequency and for receiving an inbound signal at least at one receiving frequency. Baseband signal processors are also provided for baseband processing of the outbound signal before conversion up to the transmitting frequency and of the received inbound signal after conversion down from the receiving frequency. To reduce cable laying in equipment racks and to simplify the realization of baseband frequency hopping, a bidirectional serial digital transmission channel is provided between transceivers and baseband signal processors, whereby both the inbound signal from a transceiver and the outbound signal applied to the transceiver are time-division multiplexed to said bidirectional serial digital transmission channel.
Patent NO-924679-L (NO)
Title: Kontrastmidler for ultralydbilleder
Inventor: YUDELSON JOSEPH
IPC: G01N29/00
Filed: 1992-12-04
Abstract: Partikler som har en gjennomsnittlig diameter på mindre enn ca 12 pm omfattende fettsyrekjerner Innkapslet med humanserumalbumin og fremgangsmåter for deres frem- stilling. Disse materialene er nyttige som kontrast- mldler i ultralydavbildning, de har spredningslntensl- teter som er ekvivalente med eller større enn de som oppnås fra dispergerte mikrobobler, men er mye mer stabile, både når det gjelder lagring og ved anvendelse in vivo, enn tilfellet er for kontrastmidler basert på dispergerte mikrobobler.
Patent NO-931834-L (NO)
Inventor: PETSETAKIS MENELAOS
IPC: B29C48/07
Filed: 1993-05-19
Abstract: PCT No. PCT/GR92/00017 Sec. 371 Date May 18, 1993 Sec. 102(e) Date May 18, 1993 PCT Filed Sep. 17, 1992 PCT Pub. No. WO93/05947 PCT Pub. Date Apr. 1, 1993An apparatus and method are disclosed for extruding a product which comprises a longitudinal component, e.g. a tubular sheet and/or longitudinal filaments in a circular array, and transverse filaments which follow a helical path relative to the longitudinal component, whereby the product may consist of a lattice or a reinforced sheet material. The transverse filaments are formed by cooperation between two die parts (101; 102) to which relative movement is imparted so that one part (102) performs a rocking motion progressing around a circular path to influence the extrusion orifice, without rotation of the die parts. The extrusion orifice may comprise an annular slot defined between two die members (106; 108) of the first die part (101) which is held stationary, while the second die part (102) extends around the first part and has an edge for alternatively opening and at least partially closing the slot at each point along its annular extent in response to the relative circular rocking movement imparted to the second part (FIG. 7). Alternatively, the extrusion orifice may be defined between cooperating frusto-spherical surfaces (4, 8) of the two die parts (3, 7) with the inner die part having a groove (9) which is alternately exposed and concealed due to circular rocking motion imparted to this die part (FIG. 1).
Patent NO-940417-L (NO)
Title: Anvendelse av kinolizinderivater som oreksigene midler
Inventor: BURKE JOHN T
IPC: A61P3/04
Filed: 1994-02-08
Abstract: Foreliggende oppfinnelse er rettet mot anvendelse av estere av heksahydro- 8-hydroksy-2,6-metan-2H-kinolizin-3-(4H)-on og heksahydro-8-hydroksy-2,6- metan-2H-kinoliziner ved fremstilling av et medikament for fremkallelse av en oreksigen effekt.
Patent NO-941183-L (NO)
Inventor: VANDERBEKE ERIC EUGENE MAURICE
IPC: C12N15/82
Filed: 1994-03-30
Abstract: An enzyme composition having a synergetic phytate hydrolyzing activity comprising a phytase having phytate hydrolyzing activity at a pH of from 2.5 to 5.0 and an acid phosphatase having phytate hydrolyzing activity at a pH of 2.5, in a low ratio corresponding to a pH 2.5/5.0 activity profile of from 0.8/1.0 to 3/1. Said enzyme composition preferably displays a higher synergetic phytate hydrolyzing efficiency through thermal treatment. Fungal enzymes, especially those from Aspergillus, are preferred. Use of said enzyme composition in food, feed and fodder products to improve phytate hydrolysis.
Patent NO-943862-L (NO)
Inventor: ESKA PETER
IPC: A63B47/00
Filed: 1994-10-13
Abstract: A container (1, 1', 28) has a pressure vessel for regenerating and storing tennis balls (21, 21') under a positive gas pressure, preferably a positive air pressure. The container has a bottom (3, 20, 35) and a pressure-tight lid (3', 4, 31, 31') with an inlet valve (24, 24') and a gas pump (8, 8', 34) linkable thereto. The gas pump (8) is constructively integrated inside the pressure vessel (2, 30, 30') or the container (1, 1', 28). A removable receptacle (12) made of several mutually detachable parts (13, 14) is inserted into the pressure vessel (2). The receptacle contains mutually separated recesses (15, 16) having substantially the size of tennis balls (21, 21') and interconnected by means of the inlet valve (24, 24') in such a way that gas can flow from one recess into another recess. The recesses (15, 16) are located within the parts (13, 14) that constitute the receptacle (12) and which make up chambers (15, 16) for tennis balls when the molds are aligned and assembled. An positive pressure may be applied on the tennis balls (21, 21') disposed in the chambers (15, 16) by means of the gas pump (8, 8'). A pressure relief valve (7, 7') and an outlet valve (6, 6') are integrated in the lid (3, 3') of the container and are in communication with the pressure vessel (2, 2') inside the container.
Patent NO-950533-L (NO)
Inventor: VAZQUES MICHAEL L
IPC: C07D215/48
Filed: 1995-02-13
Abstract: The present invention provides retroviral protease inhibitor compounds represented by the Formula I: <CHEM>   Such compounds are urseful for preparing medicaments for inhibiting proteases, especially for inhibiting HIV protease and for treating a retroviral infection such as HIV infection and for treating AIDS.
Patent NO-953473-L (NO)
Inventor: CHRETIEN PAUL B
IPC: A61K38/00
Filed: 1995-09-04
Abstract: A method of treating Hepatitis C by administering an immune system-potentiating dose of at least one Thymosin or system-potentiating Thymosin fragment to a mammal infected with Hepatitis C virus, which Hepatitis C infection in the mammal is non-responsive to treatment with interferon alone.
Patent NO-954123-L (NO)
Title: Universalsystem for pakking av tredimensjonale gjenstander
Inventor: TABUENCA GARCIA ANA
IPC: B65D61/00
Filed: 1995-10-17
Abstract: En sammenfoldbar transportpakning omfatter et rammeverk som er utført i form av et rektangulært prisme ved hjelp av fire langsgående bjelker (1) som er innbyrdes forbundet ved hjelp av to firkantede enderammer. Enderammene defineres av fire endestyk- ker (2) . Dette rammeverk utgjør et konstruksjonsmes- sig avstigningselement som kan oppta dekkplater (10) som overspenner prismets flater og virker som uavhen- gig fjernbare avslutningselementer. En sekundær- bj eike (17) er festet til innerflåten av hver langs- | gående bjelke (1) ved hjelp av elastiske dempere (16). Fleksible stropper (20) er anordnet mellom diagonalt motstående par av sekundærbjeikene (17), , hvilke stropper er utført for fullstendig eller delvis å henge opp den pakkede gjenstand i beholde- ren. Stroppene (20) installeres og fjernes hensikts- ; messig ved hjelp av løsbare ruller (19) som kan 1 kobles til adskilte braketter (18) som er passende j festet til sekundærbjeikene (17) .
Patent NO-954887-L (NO)
Inventor: UNEWISSE HEINZ
IPC: B21D39/04
Filed: 1995-12-01
Abstract: A process is disclosed for installing a conduit pipe system consisting of elements having a compressible area such as fittings, connectors and shaped parts, as well as conduit pipe sections (13). For that purpose, the parts to be joined are moved towards each other on a stationary pressing station until they are correctly oriented and spaced from each other. Once they are adjusted, the parts are compressed; the individual operations are preferably carried out automatically. Also disclosed is a device for carrying out the process with at least two pressing jaws (13-16) which are exchangeably arranged in a stationary press (55); the bottom platen of the press is at the same time the supporting table.
Patent NO-961640-L (NO)
Inventor: ERTEL KEITH DAVID
IPC: A61K31/445
Filed: 1996-04-24
Abstract: PCT No. PCT/US94/10972 Sec. 371 Date Jul. 3, 1996 Sec. 102(e) Date Jul. 3, 1996 PCT Filed Sep. 28, 1994 PCT Pub. No. WO95/11677 PCT Pub. Date May 4, 1995The present invention is directed to a chemically stable pharmaceutical composition containing ibuprofen in combination with terfenadine, wherein the oxidation of terfenadine to terfenadone is prevented by the presence in the composition of an  alpha -hydroxy carboxylic acid.
Patent NO-970135-L (NO)
Inventor: THOLANDER BENT
IPC: C02F3/12
Filed: 1997-01-13
Abstract: PCT No. PCT/DK95/00309 Sec. 371 Date Mar. 12, 1997 Sec. 102(e) Date Mar. 12, 1997 PCT Filed Jul. 14, 1995 PCT Pub. No. WO96/02468 PCT Pub. Date Feb. 1, 1996A method and plant for the purification of polluted water by the activated sludge method is provided in that a mixture of polluted water and recycled sludge is subjected to biological treatments in at least two treatment zones, and maintaining for a period such conditions in one of the treatment zones that a sludge precipitation occurs therein, supplying in a subsequent period the mixture of polluted water and recycled sludge directly or indirectly to the zone which, during the preceding period, served as a sludge precipitation zone prior to further treatment thereof in one or more treatment zones, and passing the treated water to a permanent clarification zone and separating it into a water fraction and a sludge fraction, at least a part of the sludge fraction being recycled and mixed with polluted water.
Patent NO-972467-L (NO)
Inventor: BEVAN BRUNO
IPC: A61K31/565
Filed: 1997-05-30
Abstract: PCT No. PCT/FR95/01696 Sec. 371 Date Jun. 11, 1997 Sec. 102(e) Date Jun. 11, 1997 PCT Filed Dec. 9, 1995 PCT Pub. No. WO96/19203 PCT Pub. Date Jun. 27, 1996A novel system for percutaneously delivering at least two active principles, consisting of at least two juxtaposed devices. The system includes (i) a first device containing a mixture of all the active principles in which at least one first active principle (A) is present in an amount enabling the effective therapeutic dose to be delivered, and at least one second active principle (B) is present in an amount smaller than the amount needed to deliver the effective therapeutic dose; and (ii) one or more additional devices each containing a single active principle (B) selected from those in the first device and provided in an amount smaller than the amount needed to deliver the effective therapeutic dose, said additional device(s) being designed to top up the amount of each of the active principles (B) in the system until the effective therapeutic dose is achieved.
Patent NO-973136-L (NO)
Inventor: CARSTENS TORKILD
IPC: F03B17/06
Filed: 1997-07-07
Abstract: Sea turbine with at least one, preferably several water wheels (16), which are connected to an elongated carrier (15) provided to be anchored in a water stream to extend perpendicular to the direction of the water stream. The carrier (15) is symmetrical round a vertical central plane, preferably with a symmetrical wing shaped for use in a bidirectional sea stream. The water wheels (16) are preferably arranged over and under the carrier (15), but can also be arranged between two parallel carriers. The carrier is provided with means to control the buoyancy, e.g ballast compartments, to be lowered and lifted in the water.
Patent NO-975724-L (NO)
Title: Fremgangsmåte for syklonseparering nede i et borehull
Inventor: PEACHEY BRUCE R
IPC: E21B43/38
Filed: 1997-12-05
Abstract: En fremgangsmåte for nedihull-syklonseparering som er mindre utsatt for problemer i tilknytning til gassutbrudd. Denne fremgangsmåte omfatter følgende trinn. Som et første trinn plasseres en syklonseparator (12) nede i en oljebrønn (14) som produserer en blandet strøm av olje, vann og gass. Syklonseparatoren (12) omfatter et separeringskammer (16) hvor væsker av ulike densiteter separeres, minst ett væskeblandingsinnløp (18) gjennom hvilket væsker strømmer inn i separeringskammeret (16), et første utløp (20) for strømning av væsker av et første densitetsområde fra separeringskammeret (16), og et andre utløp (22) for strømning av væsker av et andre densitetsområde fra separeringskammeret (16). Som et andre trinn forbindes det første utløp (20) med en utvinnings-rørledning (24) som strekker seg til overflaten. Som et tredje trinn forbindes det andre utløp (22) med en deponerings-rørledning (26) som strekker seg til et valgt deponeringssted. Fremgangsmåten er karakterisert ved at det minst ene væskeblandingsinnløpet (18), som et fjerde trinn, forbindes med en pumpe (28) og en blandet strøm av olje, vann og gass pumpes inn i syklonseparatorens (12) separeringskammer (16). Blandingsstrømmen separeres i en utvinningsstrøm av olje med redusert vanninnhold som strømmer ut av det første utløp (20) og langs utvinnings-rørledningen (24) til overflaten og en deponeringsstrøm av hovedsakelig vann som strømmer ut av det andre utløp (22) og langs deponerings-rørledningen (26) til det valgte deponeringssted.
Patent NO-981128-L (NO)
Inventor: DUVAL RAPHAUL
IPC: C08F16/12
Filed: 1998-03-13
Abstract: A method of preparing a chiral compound, involves: (1) Synthesis of an alkenyl oxy-aryl or alkenyl aryl-oxy-aryl bifunctional compound of formula: ÄR-CH=CH-(X)-OÜn-Ar-Q ; (where: Q = group that will react with the H carried by a heteroatom (O, N, S) or a precursor of such a group; n = 1 - 20; R = H-alkyl, alkoxy, OH, or aryl, optionally substituted; X = divalent alkyl having ≥ 1 C atom, or an aryl optionally substituted by alkyl, alkoxy, OH, or trihaloalkyl; Ar = aryl or polyaryl, optionally substituted with alkyl, alkoxy, OH, trihaloalkyl, silyl, thiol, aminoalkyl, amido, nitro, nitro-amino, N-amino, aldehyde, acid, or ester; (2) Reacting ≥ H on an alcohol, amine, or thiol function of a chiral unit with the group (Q) on the bifunctional compound. Also claimed is: (i) a process for the synthesis of polymers in which a bifunctional compound as described above, where specifically: Q = -NCO or its precursor, -NH2, -CON3, -COCl or its precursor, -COOH, -NCS, or -CH2-Y; Y = Cl, Br , I, methyl sulphonyl oxy, p-toluene sulphonyl oxy, or 3,5-dimethyl phenyl sulphonyl oxy; is synthesised, followed by polymerisation of the alkenyl group or the group R1 (sic) to give a polymer functionalised with group Q; (ii) Bifunctional compounds as described; (iii) Chiral compounds as described, physically deposited on a support; and (iv) Process for separating chiral compounds, or for the preparation of enantiomers, or for asymmetric synthesis, using chiral compound deposited on a support, using liquid chromatography, gas chromatography, supercritical chromatography, subcritical chromatography, centrifuge division chromatography, electrophoresis, electro-chromatography, and any membrane separation process.
Patent NO-994975-L (NO)
Inventor: HUMM SIEGFRIED
IPC: B65D83/44
Filed: 1999-10-13
Abstract: The second (8) of the two valves (5,8) for filling the container (1) takes fluid and pressurised gas. The filler valve (8) is situated on the bottom (7) of the container. The container, such as can, is placed on a filler pipe (9) which is pref. in the form of a valve opened by the filler valve. The top dispenser valve is immovably fixed to the container. A surface part of the container acts as control for an on-off valve (15) for a filler appliance (2). A metering container (11) has a filler pipe (10) leading from the outlet or bottom to the filler pipe. A pressurised gas appliance (14-16) is connected to the dispenser container.
Patent NO-995944-L (NO)
Inventor: BERGERON JR RAYMOND J
IPC: C07D213/38
Filed: 1999-12-03
Abstract: A pharmaceutical composition for the treatment of cardiac arrhythmia comprising an effective anti-arrhythmic amount of a polyamine compound in association with a pharmaceutically acceptable, substantially non-toxic carrier or excipient, and methods for the treatment of cardiac arrhythmia or effecting anti-arrhythmic action which comprise administering to a patient requiring anti-arrhythmic therapy or effect the polyamine compound.
Patent SE-0002416-L (SE)
Inventor: JOHANSSON ANDERS O
IPC: G06F21/34
Filed: 2000-06-27
Abstract: An authentication arrangement (101), such as a smart card, is identified by an authentication arrangement identification number and communicates with a communication system (102) comprising a transaction manager (110, 111) and an authentication manager (110, 111). The authentication arrangement comprises means for receiving personalizing information from the authentication manager (110, 111) associating the authentication arrangement (101) with the transaction manager (110, 111). Further, the arrangement comprises means for calculating, for a transaction that requires authentication of the user between the user and the transaction manager (110, 111), a substantially non-recurring identification code (100), which depends on the personalizing information. Also comprised in the authentication arrangement are means for supplying the identification code (100) to the user. The user is thereby enabled to authenticate with the transaction manager (110, 111).